Literature DB >> 9078278

Highly conserved residue arginine-15 is required for the Ca2+-dependent properties of the gamma-carboxyglutamic acid domain of human anticoagulation protein C and activated protein C.

A Thariath1, F J Castellino.   

Abstract

The function of the rigidly conserved amino acid residue R15 in the Ca2+/phospholipid-dependent properties of the gamma-carboxyglutamic acid (Gla)-containing domain (GD) of human Protein C (PC) were investigated through site-directed mutagenesis strategies. A series of recombinant (r) mutants, namely r-[R15K]PC, r-[R15H]PC, r-[R15L]PC, and r-[R15W]PC, were constructed, expressed and purified, and their relevant properties investigated. As revealed by intrinsic fluorescence analysis, all of the variant proteins underwent Ca2+-dependent structural transitions. Nonetheless, they displayed altered binding properties to acidic phospholipid vesicles, and also did not interact with a monoclonal antibody specific for the type of Ca2+-dependent conformation of the GD that characterizes the wild-type protein. On conversion into their activated forms, these variant enzymes possessed less than 10% of the ex vivo plasma anticoagulant activity of wild-type r-PC. Similar activities were found when the r-active PC mutants were assayed directly for inactivation of factor Va and factor VIII, in the complete prothrombinase and tenase complexes respectively. We conclude that R15 is a critical residue in allowing the GD of PC, and probably of other proteins of this class, to adopt a Ca2+-dependent conformation that allows functional phospholipid binding, thus explaining the strict conservation of this amino acid residue in GD modules of various proteins. As a result of an analysis of structural models of the Ca2+-GD complex of PC, it is postulated that hydrogen bonds between the side chain of R15 and the functionally important Gla16 residue, as well as between the side chain of R15 and the carbonyl oxygen in the peptide bond of H10, are critical for adoption of a Ca2+-dependent conformation of the GD that allows functional phospholipid binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9078278      PMCID: PMC1218193          DOI: 10.1042/bj3220309

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  Interaction of prothrombin and blood-clotting factor X with membranes of varying composition.

Authors:  G L Nelsestuen; M Broderius
Journal:  Biochemistry       Date:  1977-09-20       Impact factor: 3.162

2.  The roles of factor VII's structural domains in tissue factor binding.

Authors:  J Y Chang; D W Stafford; D L Straight
Journal:  Biochemistry       Date:  1995-09-26       Impact factor: 3.162

3.  Role of gamma-carboxyglutamic acid. An unusual protein transition required for the calcium-dependent binding of prothrombin to phospholipid.

Authors:  G L Nelsestuen
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

4.  Equilibria involved in prothrombin- and blood-clotting factor X-membrane binding.

Authors:  G L Nelsestuen; T K Lim
Journal:  Biochemistry       Date:  1977-09-20       Impact factor: 3.162

5.  Anticoagulant properties of bovine plasma protein C following activation by thrombin.

Authors:  W Kisiel; W M Canfield; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1977-12-27       Impact factor: 3.162

6.  Interaction of vitamin K dependent proteins with membranes.

Authors:  G L Nelsestuen; W Kisiel; R G Di Scipio
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

7.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

8.  The hydrophobic nature of residue-5 of human protein C is a major determinant of its functional interactions with acidic phospholipid vesicles.

Authors:  L R Jalbert; J C Chan; W T Christiansen; F J Castellino
Journal:  Biochemistry       Date:  1996-06-04       Impact factor: 3.162

9.  Properties of recombinant chimeric human protein C and activated protein C containing the gamma-carboxyglutamic acid and trailing helical stack domains of protein C replaced by those of human coagulation factor IX.

Authors:  W T Christiansen; F J Castellino
Journal:  Biochemistry       Date:  1994-05-17       Impact factor: 3.162

10.  The binding of calcium to the activation products of bovine factor IX.

Authors:  G W Amphlett; R Byrne; F J Castellino
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.